Cite

HARVARD Citation

    Loiseau, P. et al. (2022). Risk of livedo with antiphospholipid antibodies in patients with systemic lupus erythematosus: A systematic review and meta-analysis. Lupus. pp. 1595-1605. [Online]. 
  
Back to record